About immunitoAI
immunitoAI is a company based in Bengaluru (India) founded in 2020 by Trisha Chatterjee and Aridni Shah. immunitoAI has raised $8 million across 6 funding rounds from investors including LetsVenture, Apex Group and Anicut Capital. The company has 17 employees as of April 08, 2024. immunitoAI offers products and services including AI Platform. immunitoAI operates in a competitive market with competitors including AbSci, LabGenius, Ordaos, Enpicom and Alkira Bio, among others.
- Headquarter Bengaluru, India
- Employees 17 as on 08 Apr, 2024
- Founders Trisha Chatterjee, Aridni Shah
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Immunitoai Private Limited
- Date of Incorporation 28 Nov, 2020
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$8.19 K (USD)209.88as on Mar 31, 2023
-
Net Profit
-$350.25 K (USD)-51.51as on Mar 31, 2023
-
EBITDA
-$335.74 K (USD)-47.31as on Mar 31, 2023
-
Total Equity Funding
$8 M (USD)
in 6 rounds
-
Latest Funding Round
$6.1 M (USD), Series A
Nov 25, 2025
-
Investors
LetsVenture
& 22 more
-
Employee Count
17
as on Apr 08, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of immunitoAI
immunitoAI offers a comprehensive portfolio of products and services, including AI Platform.
Generates novel antibodies using AI for therapeutic development.
People of immunitoAI
Unlock access to complete
Funding Insights of immunitoAI
immunitoAI has successfully raised a total of $8M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $6.1 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in immunitoAI
immunitoAI has secured backing from 23 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include LetsVenture, Apex Group and Anicut Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment services in private credit, seed funds, growth equity, and late-stage equity for businesses in India.
|
Locked | Locked | Locked | |
|
Deep-tech venture capital investments in early-stage companies.
|
Locked | Locked | Locked | |
|
Early-stage technology companies are invested in by Jj Family Office.
|
Locked | Locked | Locked |
Investor details for immunitoAI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by immunitoAI
Investment portfolio details for immunitoAI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - immunitoAI
Detailed financials for immunitoAI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Immunitoai Comparisons
Peer comparison for immunitoAI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of immunitoAI
immunitoAI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AbSci, LabGenius, Ordaos, Enpicom and Alkira Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based technology is used for recombinant protein production in therapeutics.
|
|
| Locked | Locked | Locked |
AI-driven platform for discovering and optimizing therapeutic antibodies for treatments.
|
|
| Locked | Locked | Locked |
AI accelerator provided for biomedical research and drug discovery.
|
|
| Locked | Locked | Locked |
Developer of bioinformatics platform integrating data, automation, and AI for biologics
|
|
| Locked | Locked | Locked |
Therapeutic antibodies targeting complex membrane proteins are developed.
|
Detailed competitors of immunitoAI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Immunitoai
Complete news archive for immunitoAI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about immunitoAI
immunitoAI was founded in 2020 and raised its 1st funding round 1 year after it was founded.
immunitoAI is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Aridni Shah is the current CEO of immunitoAI. They have also founded this company.
immunitoAI is a funded company, having raised a total of $8M across 6 funding rounds to date.
As of Apr 08, 2024, the latest employee count at immunitoAI is 17.
Annual revenue of immunitoAI is $8.19K as on Mar 31, 2023.
immunitoAI was founded in 2020 in Bengaluru, India, within the biotechnology sector. An AI-driven platform is provided by the company for antibody discovery and therapeutic development. Antibody sequences are screened and ranked through imRANK to predict binding strength with antigens. Regions of antibodies are identified and mutated via imEVOLVE to enhance affinity. Operations are centered on computational tools for pharmaceutical applications in the region.
immunitoAI offers AI Platform.
immunitoAI has 23 investors. Key investors include LetsVenture, Apex Group, Anicut Capital, pi Ventures, and Jj Family Office.
The valuation of immunitoAI is $4.34M as of Feb 2024.